WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012093975) WATER SOLUBLE FORMULATIONS COMPRISING IBANDRONATE SODIUM WITH A WATER CONTENT LESS THAN 11 % BY WEIGHT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/093975    International Application No.:    PCT/TR2012/000006
Publication Date: 12.07.2012 International Filing Date: 06.01.2012
IPC:
A61K 9/14 (2006.01), A61K 31/66 (2006.01)
Applicants: BILGIC, Mahmut [TR/TR]; (TR)
Inventors: BILGIC, Mahmut; (TR)
Agent: ISCANI, Burcu; Tozkoparan Mah. General Ali Riza Gurcan Cad. Merter Is Merkezi Bagimsiz Bolum No:2/13 34173 Merter/lstanbul (TR)
Priority Data:
2011/10524 24.10.2011 TR
2011/00151 06.01.2011 TR
Title (EN) WATER SOLUBLE FORMULATIONS COMPRISING IBANDRONATE SODIUM WITH A WATER CONTENT LESS THAN 11 % BY WEIGHT
(FR) FORMULATIONS SOLUBLES DANS L'EAU COMPORTANT DE L'IBANDRONATE SODIQUE À TENEUR EN EAU INFÉRIEURE À 11 % EN POIDS
Abstract: front page image
(EN)The present invention relates to water soluble formulations prepared by using an active agent having less than 11% of water content by weight and production methods thereof. The formulations of the present invention are used in treatment and/or prevention of bone diseases such as hypercalcaemia, osteoporosis, tumoral osteolysis, malignant hypercalcaemia, metastatic bone disease, periprostatic bone loss, Paget's disease.
(FR)La présente invention porte sur des formulations solubles dans l'eau qui sont préparées à l'aide d'un agent actif ayant une teneur en eau inférieure à 11 % en poids, ainsi que sur des procédés de fabrication de ces formulations. Les formulations de la présente invention sont utilisées dans le traitement et/ou la prévention de maladies osseuses, telles que l'hypercalcémie, l'ostéoporose, l'ostéolyse tumorale, l'hypercalcémie maligne, une maladie osseuse métastasique, la perte osseuse péri-prostatique, la maladie de Paget.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)